Hepatitis C virus induces E6AP-dependent degradation of the retinoblastoma protein

Area of Science:

• Virology
• Oncology
• Molecular Biology

Background:

• Hepatitis C virus (HCV) causes persistent infections and is linked to hepatocellular carcinoma.
• The mechanisms by which HCV promotes cancer are not fully understood.
• HCV nonstructural protein 5B (NS5B) interacts with the retinoblastoma tumor suppressor protein (pRb), affecting cell cycle regulation.

Purpose of the Study:

• To elucidate the mechanism of pRb regulation by HCV.
• To investigate the role of NS5B and E6-associated protein (E6AP) in pRb degradation during HCV infection.

Main Methods:

• Infection of cultured hepatoma cells with HCV genotypes 1a and 2a.
• Analysis of pRb abundance and localization.
• Investigation of NS5B-dependent ubiquitination and proteasomal degradation of pRb.
• Use of siRNA knockdown and dominant-negative mutants for E6AP.

Main Results:

• HCV infection downregulates pRb abundance and alters its nuclear localization.
• NS5B mediates pRb ubiquitination and proteasomal degradation.
• E6AP is required for NS5B-dependent pRb ubiquitination.
• NS5B forms a complex with pRb and recruits E6AP for pRb ubiquitination.

Conclusions:

• HCV NS5B protein hijacks the E6AP ubiquitin ligase to degrade pRb.
• This disruption of pRb/E2F pathways promotes hepatocellular proliferation and genomic instability.
• The findings reveal a novel mechanism contributing to HCV-associated liver cancer development.